ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

9 links0 made here, not in the record13 judgments2 judges (the rules as one: Rule based)1 record change seen1 read an older version
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govReplaced, or read an older version
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06525298EIS-12656 as Single Agentand in Combination inPatients With SpecifiedSolid TumorsEisbach Bio GmbHPhase 1/Phase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 10 · ClinicalTrials.gov record · Version of 2026-11-10Nov 10 · Rule based · Reading set asideNov 16 · Rule based · Read againRead againCONDITIONSAdvanced Solid TumorNo longer in the registry's filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseHomologous Recombination De…No longer in the registry's filing›Nov 14 · Rule based · Not readNot readHRR DeficiencyNo longer in the registry's filing›Nov 14 · Rule based · Not readNot readDRUGSINT012277Entry “EIS-12656”, read by our name r…›Nov 16 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedINT017508Entry “PARPi”, read by our name rule›Nov 18 · Rule based · BackgroundBackgroundTrastuzumab deruxtecanIntervention entry›Nov 16 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerDarolutamideEntry “Darolutamide (BAY 1841788)”, r…›Nov 18 · Rule based · BackgroundBackgroundTrastuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · Not givenNot givenOlaparibIntervention entry›Nov 16 · Claude Opus 5.5 · Background · partnerBackground · partner

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

INT012277

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “EIS-12656”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2TrastuzumabClaude Opus 5.5Not givenRead an older version
Nov 10The record itselfClinicalTrials.gov recordVersion of 2026-11-10Record change
Nov 10The record itselfRule based · nightly checkReading set asideCurrent
Nov 14Advanced Solid TumorRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Homologous Recombination DeficiencyRule based · condition-kind ruleNot readCurrent
Nov 14HRR DeficiencyRule based · condition-kind ruleNot readCurrent
Nov 16The record itselfRule based · nightly checkRead againCurrent
Nov 16INT012277Claude Opus 5.5TestedCurrent
Nov 16Trastuzumab deruxtecanClaude Opus 5.5Background · partnerCurrent
Nov 16OlaparibClaude Opus 5.5Background · partnerCurrent
Nov 18INT012277Rule based · role ruleTestedAgrees
Nov 18INT017508Rule based · role ruleBackgroundCurrent
Nov 18Trastuzumab deruxtecanRule based · role ruleBackgroundAgrees
Nov 18DarolutamideRule based · role ruleBackgroundCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.

When a study changes after it was read

Every night, studies whose record changed are compared with the last reading. A change to sites or dates leaves the reading as it is; a reworded entry keeps it; a change to the treatments or conditions marks it to be read again.

Until it is read again, the page shows the last reading and says so.